Cross-species research shows that RNA splicing patterns, not just gene activity, track maximum lifespan in mammals, revealing ...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...
Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data March ...
PepGen (NASDAQ:PEPG) reported top-line results from the lowest-dose cohort of its Phase II FREEDOM2 multiple ascending dose ...
PepGen shared results of a trial of patients with myotonic dystrophy type 1, a disorder that causes muscle weakness. The trial measured improvements in restoring normal RNA splici ...
PepGen’s lead candidate for myotonic dystrophy type 1 barely beat the placebo in a Phase 2 trial in terms of fixing incorrect ...
Investing.com -- PepGen Ltd (NASDAQ:PEPG) shares fell 44% in after-hours trading Monday following disappointing clinical trial results for its myotonic dystrophy type 1 treatment.
Splicing tapes are used within numerous manufacturing production processes. They can be used to join two parts of a product. Their role is centered around streamlining production, making it more ...